Medical devices, healthcare technology and the business of care
510(k) clearance · K262021

Toro 71 Aspiration Catheter; Toro Aspiration Tubing

Toro Neurovascular, Inc. · Decision date Oct 21, 2026

MEDTECHLEDGER EXPLANATIONK262021

What did the FDA decide?

FDA recorded a substantially equivalent decision for K262021 on 2026-10-21, covering the Toro 71 Aspiration Catheter and Toro Aspiration Tubing, submitted by Toro Neurovascular, Inc. The listing places the device under product code NRY with a Cardiovascular specialty. Substantially equivalent in the 510(k) pathway denotes clearance to market, not premarket approval of a new device.

The available record identifies the device and applicant but does not describe the predicate device, the specific component changes, or the intended use statement. The source excerpt also does not state whether the tubing is a separately cleared accessory or part of the same submission. Those details would require the underlying FDA decision document, which is not included here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Cardiovascular
Decision date
Oct 21, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262021
Regulatory pathway
510(k) premarket notification
Product code
NRY
Decision code
SESE
Decision date
Oct 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, Thrombus Retriever.

Product code
NRY
FDA device class
2

FDA decision timeline

  1. K262021 received

    Application receipt date recorded by FDA.

  2. K262021 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code NRY

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Toro Neurovascular, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Irvine, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records